Social Media Ideas for Nasdaq: Dnut

Krispy Kreme: Impressive Q1 FCF, Still An EPS Show-Me Story

Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win

Krispy Kreme: Huge Debt Load And No Path Out Of Sales Declines

Krispy Kreme vs. Domino's Pizza: Which Consumer Goods Stock Is a Better Buy in 2026?

Global reach, diverging financials: One brand posted a net loss after revenue dipped, while the other delivered rising sales and steady margins last year.

Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval

This biotech develops therapies for neurodegenerative diseases, advancing a broad pipeline through strategic pharmaceutical partnerships.

NNB Nutrition reports 33 year over year growth expands strategic investments industry leadership in 2026

NNB Nutrition announced significant company growth and expanded investment activity as demand accelerates for next generation functional ingredients across the health wellness spor...

CAVA vs. Krispy Kreme: Which Consumer Stock Is a Better Buy in 2026?

CAVA posts double-digit revenue growth and positive net income, while Krispy Kreme pursues a turnaround amid losses and a capital-light shift.

Krispy Kreme vs. McDonald's: Which Restaurant Stock Is a Better Buy in 2026?

One company posted a $515.8 million net loss with negative free cash flow; the other generated $7.2 billion in operating cash.

Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally

This clinical-stage biotech develops antibody therapies for severe autoimmune diseases, targeting rare neuromuscular conditions.

Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish

Specializing in monoclonal antibody therapies, this clinical-stage biotech targets severe autoimmune and inflammatory diseases.

Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish

Specializing in monoclonal antibody therapies, this clinical-stage biotech targets severe autoimmune and inflammatory diseases.

Dianthus Therapeutics, Inc. (DNTH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Nutanix (NTNX) Q3 2026 Earnings Transcript

Image source: The Motley Fool. DATEWednesday, May 27, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Rajiv RamaswamiChief Financial Officer — Rukmini SivaramanVice...

Drone delivery company Matternet to go public

The company, which is working with Dave’s Hot Chicken, will go public via reverse merger

Nu Holdings (NU) Authorizes $1B Share Repurchase Program Over Next 12 Months

NSI N.V. (NIUWF) Q2 2026 Earnings Call Transcript

Nordson (NDSN) Q2 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 21, 2026 at 8:30 a.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Sundaram NagarajanExecutive Vice President and Ch...

Nordson (NDSN) Q2 2026 Earnings Transcript

Image source: The Motley Fool. DATEThursday, May 21, 2026 at 8:30 a.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Sundaram NagarajanExecutive Vice President and Ch...

Market Digest: CNP, KHC, DOCU

Nordson (NDSN) Q4 2025 Earnings Transcript

Image source: The Motley Fool. DATEDec. 11, 2025 at 8:30 a.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Sundaram NagarajanExecutive Vice President and Chief Finan...

Nordson (NDSN) Q4 2025 Earnings Transcript

Image source: The Motley Fool. DATEDec. 11, 2025 at 8:30 a.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Sundaram NagarajanExecutive Vice President and Chief Finan...

Romanian integrated agrifood company DN AGRAR publishes 2025-2030 strategy

DN AGRAR Group (BVB: DN), the largest dairy milk producer in Europe, announced its plans for the coming years and an accompanying investment plan for the development of the CUT 2 f...

Uranium Production Milestone Underscores Why Denison Mines Corp. (DNN) Is a Top Penny Stock to Buy

Navitas (NVTS) Soars 20% Ahead of Key Updates